Vaginal ring devices capable of providing sustained/controlled release of incorporated
actives are already marketed for steroidal contraception and estrogen replacement therapy …

Vaginal rings (VRs) are flexible, torus-shaped, polymeric devices designed to sustain
delivery of pharmaceutical drugs to the vagina for clinical benefit. Following first report in a …

Multipurpose prevention technologies (MPTs) that simultaneously prevent sexually
transmitted infections (STIs) and unintended pregnancy are a global health priority …

There is a renewed interest in delivering pharmaceutical products via intravaginal rings
(IVRs). IVRs are flexible torus-shaped drug delivery systems that can be easily inserted and …

TMC 120 (Dapivirine) is a potent non-nucleoside reverse transcriptase inhibitor that is
presently being developed as a vaginal HIV microbicide. To date, most vaginal microbicides …

Objectives: To evaluate evidence for the effectiveness of female controlled physical and
chemical barrier methods in preventing STI/HIV transmission, to examine recent reviews on …

There is a high global prevalence of HIV, sexually transmitted infections (STIs), and
unplanned pregnancies. Current preventative daily oral dosing regimens can be ineffective …

Vaginal rings are currently being developed for the long-term (at least 30days) continuous
delivery of microbicides against human immunodeficiency virus (HIV). Research to date has …

In this paper some of the latest studies and research works conducted on SILICONE based
DRUG DELIVERY SYSTEMS (DDS) are reviewed and some of more specific and important …

Following the successful development of long-acting steroid-releasing vaginal ring devices
for the treatment of menopausal symptoms and contraception, there is now considerable …